ClinicalTrials.Veeva

Menu

Creatine Supplementation and Diabetes

U

University of Sao Paulo

Status

Completed

Conditions

Diabetes
Renal Function

Treatments

Other: Exercise training
Dietary Supplement: creatine

Study type

Interventional

Funder types

Other

Identifiers

NCT00992043
eefeusp2

Details and patient eligibility

About

Creatine supplementation is capable of improving glucose tolerance in healthy subjects. The researchers aim to investigate whether this supplement can affect metabolic control in diabetic patients.

Enrollment

28 patients

Sex

All

Ages

45+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • males and females type 2 diabetic patients
  • glycated hemoglobin between > 9%
  • non insulin users
  • physically inactive
  • only metformin and/or sulfonylurea users
  • BMI > 30 kg/m2
  • age of years > 50 y

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

28 participants in 2 patient groups, including a placebo group

exercise and placebo
Placebo Comparator group
Treatment:
Dietary Supplement: creatine
Other: Exercise training
exercise and creatine
Experimental group
Treatment:
Dietary Supplement: creatine
Other: Exercise training

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems